Prognostic value of [18F]FLT PET in liver metastases.

Prognostic value of Fluorine-18 3-deoxy-3-fluorothymidine ([18F]FLT) uptake in resectable liver metastases of colorectal cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22686

Enrollment

100

Registered

2009-10-19

Start date

2010-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

[18F]FLT PET(-CT).

Eligibility

Inclusion criteria

Inclusion criteria: 1. Technically resecrable liver metastases at the time of hepatic recurrence diagnosis; 2. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Claustrophobia prohibiting PET-scanning; 2. Systemic cancer therapy within 3 months prior to PET; 3. Largest liver metastasis <2 cm.

Design outcomes

Primary

Measure	Time frame
Primary outcome measure: prognostic accuracy of [18F]FLT uptake in liver metastases with respect to patient outcomes (DFS).	—

Secondary

Measure	Time frame
Secundary outcome measure: prognostic accuracy of [18F]FLT uptake vs. existing prognostic indices with respect to patient outcomes (DFS).	—

Contacts

Public ContactO.S. Hoekstra

Box 7057

Outcome results